Literature DB >> 12801843

B-cell non-Hodgkin's lymphomas express heterogeneous patterns of neovascularization.

Enrico Crivellato1, Beatrice Nico, Angelo Vacca, Domenico Ribatti.   

Abstract

BACKGROUND AND OBJECTIVES: The role of angiogenesis in the growth and survival of hematologic malignancies was not clear until recently. We have previously demonstrated in beta-cell non Hodgkin's lymphomas (B-NHL), that neoplastic progression, as defined by its increasing malignancy grades, is clearly related to the degree of angiogenesis. DESIGN AND METHODS: In the present study we used transmission electron microscopy to examine the ultrastructural patterns of neovascularization in both low and high grade B-NHL). In low grade B-NHL the vessel lumen was formed either by endothelial cell body curving or, more frequently, by the fusion of intracellular vacuoles in poorly differentiated endothelial cells. In high grade B-NHL, on the other hand, the predominant neo-angiogenic pattern was the formation of a slit-like lumen. A remarkable ultrastructural feature in high-grade B-NHL was the intimate relationship between endothelial and tumor cells. Both low and high grade B-NHL exhibited development of transluminal bridges in larger vessels, leading to the division of the vessel. INTERPRETATION AND
CONCLUSIONS: These in situ data suggest that the intrinsic process of endothelial cell proliferation and vessel formation in the stroma of B-NHL varies according to the grade of tumor malignancy and point to the important role played by the specific organ microenvironment, which determines the extent of cancer cell proliferation, angiogenesis and invasion. In fact, the microenvironment has an important influence on vascular architecture, i.e., the properties of tumor cells can also determine the outcome of the angiogenic response. Taken together our findings, which provide quantitative data on different vascular patterns in B-NHL, have potential implications for vascular targeting and cancer therapy.

Entities:  

Mesh:

Year:  2003        PMID: 12801843

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  8 in total

1.  Intussusceptive microvascular growth in human glioma.

Authors:  Beatrice Nico; Enrico Crivellato; Diego Guidolin; Tiziana Annese; Vito Longo; Nicoletta Finato; Angelo Vacca; Domenico Ribatti
Journal:  Clin Exp Med       Date:  2009-10-31       Impact factor: 3.984

Review 2.  Intussusceptive angiogenesis and its counterpart intussusceptive lymphangiogenesis.

Authors:  L Díaz-Flores; R Gutiérrez; S Gayoso; M P García; M González-Gómez; L Díaz-Flores; R Sánchez; J L Carrasco; J F Madrid
Journal:  Histol Histopathol       Date:  2020-04-24       Impact factor: 2.303

Review 3.  The role of angiogenesis in human non-Hodgkin lymphomas.

Authors:  Domenico Ribatti; Beatrice Nico; Girolamo Ranieri; Giorgina Specchia; Angelo Vacca
Journal:  Neoplasia       Date:  2013-03       Impact factor: 5.715

4.  Prognostic significance of serum proangiogenic molecules in patients with de novo non-Hodgkin lymphomas.

Authors:  Pairaya Rujirojindakul; Arnuparp Lekhakula
Journal:  ScientificWorldJournal       Date:  2012-04-26

Review 5.  Tumor refractoriness to anti-VEGF therapy.

Authors:  Domenico Ribatti
Journal:  Oncotarget       Date:  2016-07-19

Review 6.  Abnormalities in alternative splicing of angiogenesis-related genes and their role in HIV-related cancers.

Authors:  Nonkululeko N Mthembu; Zukile Mbita; Rodney Hull; Zodwa Dlamini
Journal:  HIV AIDS (Auckl)       Date:  2017-03-30

Review 7.  Angiogenesis in Lymph Nodes Is a Critical Regulator of Immune Response and Lymphoma Growth.

Authors:  Lutz Menzel; Uta E Höpken; Armin Rehm
Journal:  Front Immunol       Date:  2020-12-03       Impact factor: 7.561

8.  The chick chorioallantoic membrane as an in vivo xenograft model for Burkitt lymphoma.

Authors:  Marcel Klingenberg; Jürgen Becker; Sonja Eberth; Dieter Kube; Jörg Wilting
Journal:  BMC Cancer       Date:  2014-05-18       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.